CD24 blunts oral squamous cancer development and dampens the functional expansion of myeloid-derived suppressor cells.

作者: Caroline W. Fugle , Yongliang Zhang , Feng Hong , Shaoli Sun , Caroline Westwater

DOI: 10.1080/2162402X.2016.1226719

关键词:

摘要: CD24 expression has been implicated in the oncogenesis of multiple types cancer and high tumor is considered a poor prognosis factor; however, role oral progression unknown. Unlike other types, we found that higher levels human cancers are correlated to lower clinical stage better overall survival. We then dissected mechanisms pathogenesis mice using genetic strategy demonstrated deficiency increased cavity burden response carcinogen 4-nitroquioline 1-oxide (4-NQO). Immune profile analysis showed significant expansion as well suppressive function myeloid-derived suppressor cells (MDSCs) CD24-/- mice, but no apparent impairment T cells, B or dendritic cells. Further, studies with an orthotopically transplanted syngeneic squamous carcinoma model tongue CD24+/- confirmed protective roles against cancer. Moreover, difference growth between was blunted by immunodepletion MDSCs. conclude impedes MDSC function, thus slows oncogenesis. This study first examine de novo model, it highlights need consider immune regulatory development CD24-targeted therapy for

参考文章(64)
Mei Chu, Y‐X Su, Lin Wang, T‐H Zhang, Y‐J Liang, L‐Z Liang, G‐Q Liao, None, Myeloid‐derived suppressor cells contribute to oral cancer progression in 4NQO‐treated mice Oral Diseases. ,vol. 18, pp. 67- 73 ,(2012) , 10.1111/J.1601-0825.2011.01846.X
Sergei Kusmartsev, Yulia Nefedova, Daniel Yoder, Dmitry I. Gabrilovich, Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. Journal of Immunology. ,vol. 172, pp. 989- 999 ,(2004) , 10.4049/JIMMUNOL.172.2.989
TOMOHITO TANAKA, YOSHITO TERAI, YUHEI KOGATA, KEISUKE ASHIHARA, KAZUYA MAEDA, SATOE FUJIWARA, SAHA YOO, YOSHIMICHI TANAKA, SATOSHI TSUNETOH, HIROSHI SASAKI, MASANORI KANEMURA, AKIKO TANABE, MASAHIDE OHMICHI, CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer. Oncology Reports. ,vol. 34, pp. 2282- 2288 ,(2015) , 10.3892/OR.2015.4257
Guo-Yun Chen, Xi Chen, Samantha King, Karen A Cavassani, Jiansong Cheng, Xincheng Zheng, Hongzhi Cao, Hai Yu, Jingyao Qu, Dexing Fang, Wei Wu, Xue-Feng Bai, Jin-Qing Liu, Shireen A Woodiga, Chong Chen, Lei Sun, Cory M Hogaboam, Steven L Kunkel, Pan Zheng, Yang Liu, Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction Nature Biotechnology. ,vol. 29, pp. 428- 435 ,(2011) , 10.1038/NBT.1846
Deepak Kanojia, Milind M. Vaidya, 4-Nitroquinoline-1-oxide induced experimental oral carcinogenesis Oral Oncology. ,vol. 42, pp. 655- 667 ,(2006) , 10.1016/J.ORALONCOLOGY.2005.10.013
T Barrette, A Pandey, AM Chinnaiyan, ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform Neoplasia. ,vol. 6, pp. 1- 6 ,(2004) , 10.1016/S1476-5586(04)80047-2
Jianjiang Zhao, Zhiping Wang, Jiusong Han, Xiaoling Qiu, Jie Pan, Jun Chen, Increased frequency of CD4+ CD25+ FOXP3+ cells correlates with the progression of 4-nitroquinoline1-oxide-induced rat tongue carcinogenesis. Clinical Oral Investigations. ,vol. 18, pp. 1725- 1730 ,(2014) , 10.1007/S00784-013-1146-5
T. Z. DeSantis, P. Hugenholtz, N. Larsen, M. Rojas, E. L. Brodie, K. Keller, T. Huber, D. Dalevi, P. Hu, G. L. Andersen, Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB Applied and Environmental Microbiology. ,vol. 72, pp. 5069- 5072 ,(2006) , 10.1128/AEM.03006-05
Thomas Condamine, Dmitry I. Gabrilovich, Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function Trends in Immunology. ,vol. 32, pp. 19- 25 ,(2011) , 10.1016/J.IT.2010.10.002